Filter Results :

Your search for T-Cell returned 26 reports

Sort by


Cutaneous T-Cell Lymphoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jun 2017  |  Published by:  DelveInsight
Summary'Cutaneous T-Cell Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for A...

$ 2,000.00

Read More

Peripheral T-Cell Lymphomas (PTCL) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jun 2017  |  Published by:  DelveInsight
Summary'Peripheral T-Cell Lymphomas (PTCL)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understand...

$ 2,000.00

Read More

T-Cell Leukemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jun 2017  |  Published by:  DelveInsight
Summary'T-Cell Leukemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufac...

$ 2,000.00

Read More

T-Cell Lymphomas Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jun 2017  |  Published by:  DelveInsight
Summary'T-Cell Lymphomas- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufa...

$ 2,000.00

Read More

Cutaneous T-Cell Lymphoma-Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s, “ Cutaneous T-Cell Lymphoma-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Cutaneous T-Cell Lymphoma. The DelveInsight’sReport covers the product profiles in various stages of development including Discove...

$ 1,250.00

Read More

Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s, “ Peripheral T-Cell Lymphomas (PTCL)-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Peripheral T-Cell Lymphomas (PTCL). The DelveInsight’sReport covers the product profiles in various stages of development...

$ 1,250.00

Read More

T-Cell Leukemia-Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s, “ T-Cell Leukemia-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the T-Cell Leukemia. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IN...

$ 1,250.00

Read More

T-Cell Lymphomas-Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s, “ T-Cell Lymphomas-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the T-Cell Lymphomas. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, ...

$ 1,250.00

Read More

Cutaneous T-Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jun 2017  |  Published by:  DelveInsight
Cutaneous T-Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Cutaneous T-Cell Lymphoma Report is to...

$ 2,000.00

Read More

Peripheral T-Cell Lymphomas (PTCL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jun 2017  |  Published by:  DelveInsight
Peripheral T-Cell Lymphomas (PTCL)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Peripheral T-Cell Lymphomas (...

$ 2,000.00

Read More

T-Cell Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jun 2017  |  Published by:  DelveInsight
T-Cell Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the T-Cell Leukemia Report is to understand the mark...

$ 2,000.00

Read More

T-Cell Lymphomas-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jun 2017  |  Published by:  DelveInsight
T-Cell Lymphomas-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the T-Cell Lymphomas Report is to understand the ma...

$ 2,000.00

Read More

Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2017

31 Mar 2017  |  Published by:  GlobalData
SummaryGlobalData's clinical trial report, “Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy Global Clinical Trials Review, H1, 2017" provides an overview of Angioimmunoblastic T-Cell Lymphoma (AITL)/Immunoblastic Lymphadenopathy clinical trials scenario. This report provides ...

$ 2,500.00

Read More

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2016

31 Aug 2016  |  Published by:  Global Markets Direct
Summary'Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2016', provides an overview of the Peripheral T-Cell Lymphomas (PTCL) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Peripheral T-Cell Lymphomas (PTCL), complete with analysi...

$ 2,000.00

Read More

T-Cell Leukemia Global Clinical Trials Review, H2, 2016

30 Aug 2016  |  Published by:  GlobalData
Summary“T-Cell Leukemia Global Clinical Trials Review, H2, 2016" provides an overview of T-Cell Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on T-Cell Leukemia. Report includes an overview of trial numbers and their average enrollment in top c...

$ 2,500.00

Read More
Total 26 records.